Banerjee Indraneel, Smith Nicholas Anthony, Katz Jonathan E, Gokhale Aniruddha, Shah Rashmi, Shah Hemendra Navinchandra
Department of Urology, Miller School of Medicine, University of Miami, Coral Gables, Florida, USA.
S. L. Raheja (Fortis Associate Hospital) Mumbai, Mumbai, India.
J Endourol Case Rep. 2020 Dec 29;6(4):438-441. doi: 10.1089/cren.2020.0158. eCollection 2020.
Although the prostatic urethral stents are no longer used in the United States for treatment of prostatomegaly, urologists will encounter patients with complications of previously placed permanent prostatic stents. We report two cases of persistent bothersome lower urinary tract symptoms (LUTS) after prostatic stent placement treated with simultaneous holmium laser enucleation of prostate (HoLEP) with endoscopic removal of the prostatic urethral stent using high-power holmium laser. We also reviewed the literature regarding the removal of prostatic stents with holmium laser combined with surgical management of benign prostatic hyperplasia. A 71-year-old man who presented with LUTS, recurrent gross hematuria, and urinary infection, which developed after placement of a prostatic stent 10 years prior for urinary retention secondary to prostatomegaly (80 g). He underwent combined HoLEP with endoscopic removal of the prostatic stent using 100 W holmium laser at a power setting of 2 J and 30 Hz. The surgical steps comprised fragmentation of the stent by making incisions at 5, 7, and 12 o'clock positions followed by enucleation of the prostate. The stent was then separated from enucleated tissue in the urinary bladder. The remaining prostate adenoma was then morcellated and removed. The patient remained asymptomatic at 10-year follow-up. Another patient was 62-year-old man who developed recurrence of bothersome LUTS, 1 year after placement a prostatic stent for urinary retention. On investigation his prostate was 105 g and stent showed partial migration in the bladder with overlying calcification. HoLEP and stent removal was performed in a manner similar to the first patient. This patient also remained asymptomatic at a 1-year follow-up. Combined HoLEP with removal of a prostatic urethral stent using a high-power holmium laser is safe and effective with long-term durable outcome.
尽管前列腺尿道支架在美国已不再用于治疗前列腺增生,但泌尿科医生仍会遇到曾植入永久性前列腺支架并出现并发症的患者。我们报告了两例前列腺支架置入术后持续存在令人困扰的下尿路症状(LUTS)的病例,采用钬激光前列腺剜除术(HoLEP)同时使用高功率钬激光在内镜下取出前列腺尿道支架进行治疗。我们还回顾了有关使用钬激光取出前列腺支架并结合良性前列腺增生手术治疗的文献。一名71岁男性,因10年前因前列腺增生(80克)导致尿潴留而植入前列腺支架后出现LUTS、反复肉眼血尿和泌尿系统感染。他接受了联合HoLEP手术,使用100W钬激光,功率设置为2J和30Hz,在内镜下取出前列腺支架。手术步骤包括在5点、7点和12点位置切开使支架破碎,随后进行前列腺剜除。然后将支架与膀胱内剜除的组织分离。接着将剩余的前列腺腺瘤切碎并切除。患者在10年随访中无症状。另一例患者是一名62岁男性,在因尿潴留植入前列腺支架1年后出现令人困扰的LUTS复发。经检查,他的前列腺为105克,支架显示部分移入膀胱并伴有钙化。以与首例患者相似的方式进行了HoLEP和支架取出术。该患者在1年随访中也无症状。联合HoLEP并使用高功率钬激光取出前列腺尿道支架是安全有效的,且具有长期持久的效果。